Research Article
Open Access
A serum proteome signature to predict mortality in severe COVID-19 patients
Franziska Völlmy, Henk van den Toorn, Riccardo Zenezini Chiozzi, Ottavio Zucchetti, Alberto Papi, Carlo Alberto Volta, Luisa Marracino, Francesco Vieceli Dalla Sega, Francesca Fortini, Vadim Demichev, View ORCID ProfilePinkus Tober-Lau, Gianluca Campo, Marco Contoli, Markus Ralser, Florian Kurth, View ORCID ProfileSavino Spadaro, Paola Rizzo, View ORCID ProfileAlbert JR Heck Correspondence email
Franziska Völlmy
1Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands
2Netherlands Proteomics Center, Utrecht, The Netherlands
Henk van den Toorn
1Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands
2Netherlands Proteomics Center, Utrecht, The Netherlands
Riccardo Zenezini Chiozzi
1Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands
2Netherlands Proteomics Center, Utrecht, The Netherlands
Ottavio Zucchetti
3Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, University of Ferrara, Ferrara, Italy
Alberto Papi
4Respiratory Section, Department of Translational Medicine, University of Ferrara, Ferrara, Italy and Respiratory Disease Unit, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy
Carlo Alberto Volta
5Department of Translational Medicine University of Ferrara, Ferrara, Italy and Intensive Care Unit, Azienda Ospedaliero-Universitaria di Ferrara, Italy
Luisa Marracino
6Department of Translational Medicine and Laboratory for Technology of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy
Francesco Vieceli Dalla Sega
7Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy
Francesca Fortini
7Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy
Vadim Demichev
8Charité–Universitätsmedizin Berlin, Department of Biochemistry, Berlin, Germany
9The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London, UK
10The University of Cambridge, Department of Biochemistry and Cambridge Centre for Proteomics, Cambridge, UK
Pinkus Tober-Lau
11Charité–Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany
Gianluca Campo
3Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, University of Ferrara, Ferrara, Italy
7Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy
Marco Contoli
4Respiratory Section, Department of Translational Medicine, University of Ferrara, Ferrara, Italy and Respiratory Disease Unit, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy
Markus Ralser
8Charité–Universitätsmedizin Berlin, Department of Biochemistry, Berlin, Germany
9The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London, UK
Florian Kurth
11Charité–Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany
12National Phenome Centre and Imperial Clinical Phenotyping Centre, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Savino Spadaro
5Department of Translational Medicine University of Ferrara, Ferrara, Italy and Intensive Care Unit, Azienda Ospedaliero-Universitaria di Ferrara, Italy
Paola Rizzo
6Department of Translational Medicine and Laboratory for Technology of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy
7Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy
Albert JR Heck
1Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands
2Netherlands Proteomics Center, Utrecht, The Netherlands
Published 5 July 2021. DOI: 10.26508/lsa.202101099
A proteome signature predicting COVID-19 mortality
Franziska Völlmy, Henk van den Toorn, Riccardo Zenezini Chiozzi, Ottavio Zucchetti, Alberto Papi, Carlo Alberto Volta, Luisa Marracino, Francesco Vieceli Dalla Sega, Francesca Fortini, Vadim Demichev, Pinkus Tober-Lau, Gianluca Campo, Marco Contoli, Markus Ralser, Florian Kurth, Savino Spadaro, Paola Rizzo, Albert JR Heck
Life Science Alliance Jul 2021, 4 (9) e202101099; DOI: 10.26508/lsa.202101099
A proteome signature predicting COVID-19 mortality
Franziska Völlmy, Henk van den Toorn, Riccardo Zenezini Chiozzi, Ottavio Zucchetti, Alberto Papi, Carlo Alberto Volta, Luisa Marracino, Francesco Vieceli Dalla Sega, Francesca Fortini, Vadim Demichev, Pinkus Tober-Lau, Gianluca Campo, Marco Contoli, Markus Ralser, Florian Kurth, Savino Spadaro, Paola Rizzo, Albert JR Heck
Life Science Alliance Jul 2021, 4 (9) e202101099; DOI: 10.26508/lsa.202101099
In this Issue
Volume 4, No. 9
September 2021
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- Integrated multiomics implicates dysregulation of ECM and cell adhesion pathways as drivers of severe COVID-associated kidney injury
- Longitudinal fluctuations in protein concentrations and higher-order structures in the plasma proteome of kidney failure patients subjected to a kidney transplant
- COVIDpro: Database for mining protein dysregulation in patients with COVID-19
- The human host response to monkeypox infection: a proteomic case series study
- A multiplex protein panel assay determines disease severity and is prognostic about outcome in COVID-19 patients